Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …

Background and Objective There are few studies comparing lesion evolution across different
CNS demyelinating diseases, yet knowledge of this may be important for diagnosis and …

Background and Objectives Relapsing-remitting multiple sclerosis (RRMS), aquaporin-4
antibody–positive neuromyelitis optica spectrum disorder (AQP4-NMOSD), and myelin …

Inflammatory myelopathies can manifest with a combination of motor, sensory and
autonomic dysfunction of variable severity. Depending on the underlying etiology, the …

Objective To identify factors predictive of relapse risk and disability in myelin
oligodendrocyte glycoprotein associated disease (MOGAD). Setting Patients were seen by …

Neuromyelitis optica (NMO) spectrum disorder (NMOSD) is a relapsing inflammatory
disease of the CNS, characterized by the presence of serum aquaporin 4 (AQP4) …

Myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are rare in
both children and adults, and have been recently suggested to be an autoimmune …

Importance The recognition of magnetic resonance imaging (MRI) features associated with
distinct causes of myelitis in children is essential to guide investigations and support …

PURPOSE OF REVIEW This article reviews the cardinal clinical features, distinct
immunopathology, current diagnostic criteria, relapse-related risk factors, emerging …